Determinants of mobility decline in nephrology-referred patients with CKD: a longitudinal cohort study
Bae, S. R.; Goodson, D. A.; Vargas, C. R.; Kim, T. Y.; Begue, G.; Delgado, C.; Robinson-Cohen, C.; Gamboa, J.; Himmelfarb, J.; de Boer, I. H.; Kestenbaum, B.; Roshanravan, B.
Show abstract
Background and ObjectiveChronic kidney disease (CKD) is associated with loss of muscle quality leading to mobility limitation and decreased independence. Identifying predictors of gait speed decline may help target rehabilitative therapies to those at highest risk of mobility impairment. Design, setting and participants, and measurementsThe current prospective cohort study recruited ambulatory patients with stage 1-4 CKD (eGFR 15-89 ml/min/1.73m2) from nephrology clinics. Predictors included demographic and clinical variables including GFR estimated using serum cystatin C. Outcomes were average change in gait speed (m/s) per year and inclusion in the top tertile of gait speed decline over 3 years. Linear mixed models and relative risk regression were used to estimate associations with annual gait speed changes and fastest tertile of decline. ResultsAmong 213 participants, 81% were male, 22% were black and 43% had diabetes. Mean age was 57{+/-}13 years, median follow-up 3.15 years, mean baseline eGFRcysc 47.9{+/-}21ml/min/1.73 m2, and median baseline gait speed 0.95m/s [IQR 0.81, 1.10]. Lower baseline eGFRcysc was associated with more rapid loss of gait speed (-0.029 m/s/year [95% CI -0.042, -0.015] per 30 ml/min/1.73 m2 lower eGFR; p<0.001). Diabetes was associated with -0.024m/s/year faster change (95% CI -0.042, -0.007; p=.007). Lower eGFRcysc was associated with a 49% greater risk of rapid gait speed decline (IRR 1.49; 95% CI 1.11, 2.00, p=.008) after adjustment. Prevalent cardiovascular disease and African American race were associated with a 45% greater (IRR 1.45; 95% CI 1.04, 2.01, p=.03) and 58% greater rate of rapid gait speed decline (IRR 1.58; 95% CI 1.09, 2.29, p=.02), respectively. ConclusionsAmong ambulatory, disability-free patients with CKD, lower eGFRcysc and diabetes status were associated with faster gait speed decline. Lower eGFRcysc, cardiovascular disease, and African American race were associated with rapid gait speed decline.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- HBA Copy Number and Kidney Disease Risk among Black Americans: a Longitudinal Cohort Study 95%
- Clonal hematopoiesis of indeterminate potential is associated with worse kidney function and anemia in a cohort of patients with advanced chronic kidney disease 95%
- Clonal hematopoiesis of indeterminate potential contributes to accelerated chronic kidney disease progression 95%
Similar papers in this journal
- Trajectories of atherosclerotic cardiovascular disease risk scores as a predictor for incident chronic kidney disease 94%
- Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or cystatin C among young people living with HIV in Uganda 94%
- Health-related hope and reduced distress associated with fluid and dietary restrictions in advanced chronic kidney disease and dialysis: a cohort study 93%
Similar papers in this journal
- Impaired incretin homeostasis in non-diabetic moderate-severe CKD 96%
- Circulating Plasma Biomarkers in Biopsy-Confirmed Kidney Disease: Results from the Boston Kidney Biopsy Cohort 93%
- Comparison of low eGFR prevalence and prediction for mortality using 2009 and 2021 CKD-EPI equations in Mexican adults 92%
Similar papers in this journal
- Cardiovascular disease protein biomarkers are associated with kidney function: the Framingham Heart Study 95%
- Progression of chronic kidney disease among black patients attending a tertiary hospital in Johannesburg, South Africa 94%
- Evaluating the kidney disease progression using a comprehensive patient profiling algorithm: A hybrid clustering approach 93%
Similar papers in this journal
- Nephron Number and Kidney Outcomes in IgA Nephropathy: A Retrospective Cohort Study 93%
- Biopsychosocial correlates of somatic symptom burden in chronic kidney disease: results of the Hamburg City Health Study (HCHS) 92%
- Pharmacogenomics of hypertension in chronic kidney disease: the CKD-PGX study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.